Skip to content

Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic Surgery

Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic Surgery: a Randomized Controlled Study.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00719017
Enrollment
24
Registered
2008-07-21
Start date
2007-09-30
Completion date
2014-06-30
Last updated
2013-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Stage Endometrial Cancer

Keywords

Brachytherapy, Early stage edometrial cancer, Quality of life, Recurrence, Treatment, Vaginectomy

Brief summary

Recent findings have suggested that laparoscopic surgery is safe and effective, as well as laparotomic one, for treating patients with early stage endometrial cancer (ESEC). Moreover, our long-term previous data have shown a trend in vaginal cuff recurrence in subjects who underwent laparoscopic approach to ESEC consisting of extrafascial hysterectomy, bilateral salpingo-oophorectomy, pelvic +/- para-aortic nodes dissections, regardless grading or lymphovascular space invasion. Based on these considerations, the aim of the current protocol-study will be to compare two different strategies for vaginal cuff recurrences prevention in patients affected by ESEC treated with laparoscopic surgery. In particular, upper vaginectomy followed by observation will be compared to post-operative brachytherapy.

Detailed description

Women with ESEC scheduled for laparoscopic surgery will be enrolled and randomized in three arms \[vaginectomy group (VG), brachytherapy group (BG), and control group (CG)\]. All laparoscopic procedures will consist of total hysterectomy, bilateral salpingo-oophorectomy, peritoneal washing, systematic inspection of peritoneal cavity and biopsy of each suspect lesion, and pelvic (and eventual para-aortic) lymphadenectomy. In VG an upper vaginecomy will be added to standard laparoscopic procedures followed by observation, whereas BG will receive post-operative brachytherapy. CG will be treated with standard protocol for management of ESEC according to National Comprehensive Cancer Network (www.nccn.org). Safety and efficacy data will be recorded in each group for 24 months of follow-up. Data will be analyzed using the intention-to-treat principle and a P value of 0.05 or less will be considered significant.

Interventions

PROCEDUREUpper vaginectomy

Laparoscopic surgery with upper vaginectomy

RADIATIONPost-operative brachytherapy

Laparoscopic surgery followed by brachytherapy

Laparoscopic surgery +/- brachytherapy +/- pelvic radiation

Sponsors

University Magna Graecia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Early stage endometrial cancer

Exclusion criteria

* Other pre-malignancies and malignancies * Major medical conditions * Psychiatric disorders * Current or past history of acute or chronic physical illness * Premenstrual syndrome (PMS) * Current or past (within 6 months from study enrolment) use of drugs influencing cognition, vigilance, and/or mood.

Design outcomes

Primary

MeasureTime frame
Vaginal cuff recurrences24 months

Secondary

MeasureTime frame
Adverse events24 months
Loco-regional recurrence rate24 months
Post-operative complicationssix months
Quality of life24 months
Overall survival24 months
Distant recurrence rate24 months

Countries

Italy

Contacts

Primary ContactStefano Palomba, MD
stefanopalomba@tin.it+39-0961.883234

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026